SHOCKWAVE MEDICAL INC (SWAV) Forecast, Price Target & Analyst Ratings

NASDAQ:SWAV • US82489T1043

Current stock price

334.75 USD
-0.08 (-0.02%)
At close:
334.8 USD
+0.05 (+0.01%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for SHOCKWAVE MEDICAL INC (SWAV).

Forecast Snapshot

Consensus Price Target

Price Target
$330.75
-1.19% Downside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 5, 2024
Period
Q2 / 2024
EPS Estimate
$1.19
Revenue Estimate
232M
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
53.75%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$330.75
Upside
-1.19%
From current price of $334.75 to mean target of $330.75, Based on 16 analyst forecasts
Low
$252.50
Median
$341.70
High
$365.84

Price Target Revisions

1 Month
2.57%
3 Months
25.91%

Price Target Summary

16 Wall Street analysts provided a forecast for the next 12 months for SWAV. The average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75.
The average price target has been revised upward by 25.91% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

SWAV Current Analyst RatingSWAV Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 2 4 6 8 10

Analyst Ratings History

SWAV Historical Analyst RatingsSWAV Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 5 10 15

Analyst Ratings Consensus

ChartMill Buy Consensus
53.75%
SWAV was analyzed by 16 analysts. The buy percentage consensus is at 54. So analysts seem to be rather neutral about SWAV.
In the last month the buy percentage fell by 15 points. So the trust of analysts is decreasing.
SWAV was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-04-08Leerink PartnersDowngrade Outperform -> Market Perform
2024-04-08CL KingDowngrade Buy -> Neutral
2024-04-08Deutsche BankDowngrade Buy -> Hold
2024-04-08Morgan StanleyDowngrade Overweight -> Equal-Weight
2024-04-05Wolfe ResearchDowngrade Outperform -> Peer Perform
2024-04-05NeedhamDowngrade Buy -> Hold
2024-04-05Canaccord GenuityDowngrade Buy -> Hold
2024-04-02Piper SandlerMaintains Overweight -> Overweight
2024-03-27CL KingInitiate Buy
2024-02-16NeedhamMaintains Buy -> Buy
2024-02-16Wells FargoMaintains Equal-Weight -> Equal-Weight
2024-02-16Piper SandlerMaintains Overweight -> Overweight
2023-12-04Morgan StanleyMaintains Overweight -> Overweight
2023-11-07NeedhamMaintains Buy -> Buy
2023-11-07Morgan StanleyMaintains Overweight -> Overweight
2023-10-24NeedhamMaintains Buy -> Buy
2023-10-16Leerink PartnersInitiate Outperform
2023-09-29UBSInitiate Neutral
2023-08-10Morgan StanleyMaintains Overweight -> Overweight
2023-08-08NeedhamMaintains Buy -> Buy
2023-08-08Wells FargoMaintains Equal-Weight -> Equal-Weight
2023-07-10Morgan StanleyUpgrade Equal-Weight -> Overweight
2023-05-09Deutsche BankMaintains Buy
2023-05-09NeedhamMaintains Buy
2023-05-09OppenheimerReiterate Underperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 5, 2024
Period
Q2 / 2024
EPS Estimate
$1.19
Revenue Estimate
232M
Revenue Q2Q
28.77%
EPS Q2Q
56.76%
Number of Analysts
14

Next Earnings Revisions

Revenue (1 Month)
0.35%
Revenue (3 Months)
0.36%
EPS (1 Month)
-2.66%
EPS (3 Months)
-2.74%

Next Earnings Summary

SWAV is expected to report earnings on 8/5/2024. The consensus EPS estimate for the next earnings is 1.19 USD and the consensus revenue estimate is 232.00M USD.
The next earnings revenue estimate has been revised upward by 0.36% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2024 - 2030

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
SWAV revenue by date.SWAV revenue by date.
237.1M
249.71%		489.7M
106.54%		730.23M
49.12%		946.59M
29.63%		1.155B
22.02%		1.4B
21.21%		1.652B
18.00%		1.852B
12.11%		2.186B
18.03%		2.501B
14.41%
EBITDA
YoY % growth
SWAV ebitda by date.SWAV ebitda by date.
2.7M
104.23%		129M
4,677.78%		169.451M
31.36%		265.92M
56.93%		311.48M
17.13%		459.79M
47.61%		596.44M
29.72%		N/AN/AN/A
EBIT
YoY % growth
SWAV ebit by date.SWAV ebit by date.
-900K
98.63%		124.1M
13,888.89%		159.093M
28.20%		220.45M
38.57%		299.89M
36.04%		391.68M
30.61%		499.51M
27.53%		560.86M
12.28%		N/AN/A
Operating Margin
SWAV operating margin by date.SWAV operating margin by date.
-0.38%25.34%21.79%23.29%25.96%27.98%30.24%30.28%N/AN/A
EPS
YoY % growth
SWAV eps by date.SWAV eps by date.
-0.30
84.92%		3.17
1,156.67%		3.87
22.08%		5.27
36.11%		6.31
19.71%		7.41
17.44%		8.86
19.63%		8.69
-1.90%		N/AN/A

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		1.19
56.76%		1.25
35.70%		1.51
30.14%		1.42
-1.36%		1.57
31.68%		1.62
30.07%		1.82
20.33%		1.63
14.79%		1.82
15.99%		1.90
16.80%		2.11
16.40%
Revenue
Q2Q % growth		232M
28.77%		236.59M
27.19%		259M
27.60%		260.5M
19.06%		284.43M
22.60%		290.48M
22.78%		320.82M
23.87%		295.9M
13.59%		322.73M
13.47%		328.95M
13.24%		367.2M
14.46%
EBITDA
Q2Q % growth		69.384M
89.06%		75.432M
48.20%		80.549M
50.17%		78.035M
71.45%		86.404M
24.53%		91.764M
21.65%		102.14M
26.80%		99.96M
28.10%		109.14M
26.31%		110.16M
20.05%		125.46M
22.83%
EBIT
Q2Q % growth		51.568M
59.16%		54.539M
25.09%		66.035M
52.57%		58.877M
38.84%		69.039M
33.88%		72.392M
32.73%		86.012M
30.25%		79.152M
34.44%		86.292M
24.99%		88.026M
21.60%		98.226M
14.20%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

SWAV Yearly Revenue VS EstimatesSWAV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
SWAV Yearly EPS VS EstimatesSWAV Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 2 -2 4 6 8

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
24.15%
EPS Next 5 Year
17.56%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
23.61%
Revenue Next 5 Year
20.10%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
41.48%
EBIT Next 5 Year
38.45%
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

SHOCKWAVE MEDICAL INC / SWAV Forecast FAQ

What is the price target for SWAV stock?

16 analysts have analysed SWAV and the average price target is 330.75 USD. This implies a price decrease of -1.19% is expected in the next year compared to the current price of 334.75.

Can you provide the upcoming earnings date for SHOCKWAVE MEDICAL INC?

SHOCKWAVE MEDICAL INC (SWAV) will report earnings on 2024-08-05, after the market close.

What are the consensus estimates for SHOCKWAVE MEDICAL INC (SWAV) next earnings?

The consensus EPS estimate for the next earnings of SHOCKWAVE MEDICAL INC (SWAV) is 1.19 USD and the consensus revenue estimate is 232.00M USD.

Can you provide the consensus rating for SHOCKWAVE MEDICAL INC stock?

The consensus rating for SHOCKWAVE MEDICAL INC (SWAV) is 53.75 / 100 . This indicates that analysts generally have a neutral outlook on the stock.